Effect of N-Acetyl-cysteine On platelet Engraftment post Auto-HSCT
Phase 3
Recruiting
- Conditions
- Condition 1: MULTIPLE MYELOMA. Condition 2: LYMPHOMA. Condition 3: Auto-Hsct.Multiple myelomaHodgkin lymphomaC90.0
- Registration Number
- IRCT20211123053165N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Patients with Multiple Myeloma who are eligible for Auto-HSCT
Patients with Lymphoma who are eligible for Auto-HSCT
Exclusion Criteria
History Of Allergic Reaction to N-Acetyl cysteine or its ingredients
History of Bronchial Asthma
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Median Platelet number post auto-Hsct. Timepoint: During admition daily then weekly for at least 3 weeks. Method of measurement: complete blood count test.
- Secondary Outcome Measures
Name Time Method